Synopsis: Citi maintains a Buy on LIC with 68% upside, citing expected market share recovery, improved margins from better product mix, undervaluation concerns easing, and potential stock re-rating. This company offers participating insurance products and...
Synopsis: Shares of Innova Captab Ltd surged 16% after the company reported 42% YoY Q3 revenue growth, strong profit performance and announced an interim dividend of ₹2 per share for FY26. This is an integrated pharmaceutical company in India with a presence across...
Synopsis: Home First Finance shares rose 7% to Rs. 1,110.65 after Q3 results showed 19% YoY sales growth, 44% net profit surge, 33% AUM CAGR, and a reduced cost-to-income ratio, with Morgan Stanley seeing 48% upside. This is a leading affordable housing finance...
Synopsis: Cipla’s Q3 net profit fell 57% YoY to Rs. 674 cr due to a Rs. 1,107 cr acquisition of diabetes drug rights and a Rs. 276 cr rise in gratuity and leave liabilities under India’s new labour codes. This is one of the leading Indian pharmaceutical companies...
Synopsis: Several Indian banks, including Bank of India, Indian Overseas Bank, Yes Bank, Union Bank, and HDFC Bank, reported lower net NPAs in Q3FY26, supported by strong profit growth, higher net interest income, and improving asset quality. In Q3FY26, several Indian...
Synopsis: Radico Khaitan shares rose 6 percent after strong Q3FY26 results, reporting 19.5 percent revenue growth, 45 percent YoY EBITDA growth by 45 percent to Rs. 265 crore, 62 percent net profit jump to Rs. 155 crore. This company is one of the most recognised IMFL...
Synopsis: Ujjivan Small Finance Bank, focused on financial inclusion, reported a 71% YoY and 49% QoQ rise in net profit to Rs. 182 cr in Q3FY26, with total income at Rs. 2,047 cr. This is a mass market-focused bank in India, catering to financially unserved and...
Synopsis: Sigachi Industries is in focus after achieving a key R&D milestone in Cystic Fibrosis APIs, targeting Rs. 250 crore annual revenue from Q4 FY27, strengthening its move into complex, high-value speciality pharmaceuticals. This company is one of the...
Synopsis: Dalmia Bharat shares gained 2% after Q3FY26 results, with revenue rising 10% YoY, net profit nearly doubling to Rs. 128 crore, and sales volumes increasing 9.5%, signalling strong performance. This company is engaged in the business of manufacturing and...
Synopsis: Maruti Securities shares jumped over 10% after Maruti Global Industries secured a Rs. 9.54 crore railway track work order from KMC Constructions, part of a South Central Railways EPC project, strengthening its infrastructure execution outlook. This company...
